Eton Pharmaceuticals, Inc.
Ticker: 1710340
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 37.59+54.9% | 24.27+8.1% | 22.46+18.6% | 18.93+9.5% | 17.28+67.4% | 10.32+13.8% | 9.07+13.8% | 7.97 |
| Total Income | 37.59+54.9% | 24.27+8.1% | 22.46+18.6% | 18.93+9.5% | 17.28+67.4% | 10.32+13.8% | 9.07+13.8% | 7.97 |
| EXPENSES | ||||||||
| Expenditure | 24.80+13.5% | 21.85-8.3% | 23.82+16.8% | 20.40+14.9% | 17.75+80.8% | 9.82-18.2% | 12.01+36.9% | 8.77 |
| Tax | 0.14+600.0% | 0.02+166.7% | -0.03-142.9% | 0.07+0.0% | 0.07+153.8% | -0.13-360.0% | 0.05 | 0.00 |
| PROFIT | ||||||||
| PBT | 11.72+646.5% | 1.57+180.1% | -1.96+22.2% | -2.52-68.0% | -1.50-400.0% | 0.50+116.7% | -2.99-269.1% | -0.81 |
| Net Profit | 11.58+647.1% | 1.55+180.3% | -1.93+25.5% | -2.59-65.0% | -1.57-349.2% | 0.63+120.7% | -3.04-275.3% | -0.81 |
| KEY METRICS | ||||||||
| OPM % | 34.04%+24.09pp | 9.95%+16.02pp | -6.07%+1.72pp | -7.79%-5.07pp | -2.72%-7.65pp | 4.93%+37.27pp | -32.34%-22.30pp | -10.04% |
| NPM % | 30.80%+24.40pp | 6.40%+14.98pp | -8.58%+5.08pp | -13.66%-4.56pp | -9.10%-15.17pp | 6.07%+39.59pp | -33.51%-23.33pp | -10.18% |
| EPS | 0.42+600.0% | 0.06+185.7% | -0.07+30.0% | -0.10-66.7% | -0.06-400.0% | 0.02+116.7% | -0.12-300.0% | -0.03 |
Corporate Events
Board MeetingETON
202631Jul
Board Meeting
Danka Radosavljevic appointed as Chief Operating Officer. D…
SEC Filing ↗ Board MeetingETON
20269Jun
Board Meeting
Annual Meeting of Stockholders to elect directors and ratify…
SEC Filing ↗